熱門資訊> 正文

Surmodics与Premier达成血栓切除产品协议

2024-06-10 20:08

Surmodics (NASDAQ:SRDX) awarded a group purchasing agreement for thrombectomy products with Premier, effective June 1, 2024.
The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Surmodics Pounce and Pounce Venous Thrombectomy Systems.
Premier is a healthcare improvement company, uniting an alliance of more than 4,350 U.S. hospitals.

More on Surmodics

Surmodics jumps 18% on acquisition by GTCR
Surmodics beats top-line and bottom-line estimates; updates FY24 outlook
Seeking Alpha’s Quant Rating on Surmodics
Historical earnings data for Surmodics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。